Search for: "Mark et al v. Eli Lilly and Company"
Results 1 - 20
of 22
Sorted by Relevance
|
Sort by Date
24 Mar 2010, 4:45 am
Eli Lilly & Co. [read post]
6 Jan 2010, 3:32 am
Ipsen Pharma, S.A.S. et al. [read post]
8 Oct 2019, 9:44 am
”) Eli Lilly and Company v. [read post]
18 Mar 2010, 2:30 am
: The Medicines Company v David Kappos et al (FDA Law Blog) Advate (Antihemophilic) – US: False marking complaint filed in N D Illinois: Simonian v. [read post]
27 Apr 2010, 10:58 pm
Orthofix International N.V. et al. [read post]
13 May 2010, 4:58 pm
(Patent Docs) Evista (Raloxifene) – US: Patent infringement complaint following a Paragraph IV certification: Eli Lilly & Company v. [read post]
17 Feb 2010, 5:10 am
USA, Inc; Eli Lilly & Co. v. [read post]
7 Jun 2009, 2:15 pm
The brief of Whealan et al. included the text:Research universities and small biotechnology companies will be disadvantaged. [read post]
7 Aug 2012, 5:02 pm
Eli Lilly and Company, et al., Civil Action No. 2:12-62 and Marston v. [read post]
19 Dec 2019, 9:41 am
Back on the terra firma of the Patents Court, Mr Justice Arnold (as he then was) was asked by Teva et al to provide his judgment in light of the CJEU's decision. [read post]
22 Apr 2024, 5:00 am
Inst. v. [read post]
6 Feb 2009, 5:00 am
Stem cell research under Obama (Ars Technica) US: Oxford Gene Technology settles legal action with Bioarray Solutions over patents covering use of microassays for detection of DNA sequence variations (Patent Docs) US: BPAI affirms rejection of claims to an isolated protein over prior art disclosing nucleic acid encoding the protein: Ex parte Chuang (not precedential) (Patent Docs) (Post-Grant) US: Supreme petitioned to grant certiorari in two cases important to biotech patenting: In re Bilski and… [read post]
24 Feb 2017, 12:04 pm
The most striking example of apparently mistaken incontestability comes from B&B v. [read post]
8 Feb 2008, 7:00 pm
– Facebook’s contractual rights to users’ photos problematic: (Spicy IP)PharmaEuropean Commission probes pharmaceutical sector: (Philip Brooks),WHO Board sets course on IP, avian flu, tighter publication policy: (Intellectual Property Watch),India: The Competition Act, patents and over hyped drugs: (Part I - Spicy IP), (Part II – Spicy IP), (Part III – Spicy IP),Ignoring not the solution –… [read post]
7 Oct 2011, 4:18 am
Hise (Technology & Marketing Law Blog) Supreme Court confirms that a download is not a performance: ASCAP v United States (1709 Copyright Blog) (Ars Technica) District Court S D New York: Court nukes another mass defendant file-sharing lawsuit: Digiprotect v Does (Technology & Marketing Law Blog) District Court E D Virginia calls out copyright trolls’ coercive business model, threaten sanctions K-Beech v Does 1–85 (EFF) (Ars Technica) District Court… [read post]
15 Mar 2008, 7:00 am
Shame about the IP: (Afro-IP),Ethiopia receives US trade mark for Sidamo coffee despite opposition from Starbucks: (The IP Factor), (Afro-IP),CC licensed test for African sleeping sickness: (creativecommons.org),Update on PCT applications filed in Nigeria: (Afro-IP),Parallel imports of DVDs to be tested in South Africa: Universal City Studios v Mr Video: (Afro-IP),The W****D C*P of 2*1*: FIFA’s intellectual property rights in South Africa: (Afro-IP),Namibia to… [read post]
9 Aug 2008, 1:50 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: The end of William Patry’s blog: (Patry Copyright Blog), (Excess Copyright), (Patently-O), (Chicago IP Litigation Blog), (Michael Geist), (The Fire of Genius), (Techdirt), (Patry Copyright Blog), Kitchin J clarifies scope of biotech patents, in particular gene sequence patents: Eli Lilly & Co v Human… [read post]
11 Jul 2008, 4:30 am
Part I – Spicy IP), India: Discussion of grant of Indian patents to Cipla for Fosamax derivative and Nexium derivative: (Spicy IP), India: Draft National Biotechnology Regulatory Authority Bill: (Spicy IP), Ivory Coast: Ivorians increasingly choose fake medicines on price: (Afro-IP), Mexico: New Mexican medicaments approvals regime: an early report: (IP tango), UK: Leave to appeal refused in trade mark infringement proceedings between Eli Lilly and 8PM Chemist… [read post]
30 May 2008, 9:09 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: WHO members near accord on global strategy on IP and health: (Intellectual Property Watch), (GenericsWeb), (Gowlings), (IAM), Copiepresse seeks up to €49 million from Google in lawsuit over right to feature links to publishers’ content on internet: (IPKat), (Ars Technica), (Techdirt), (Out-Law), (IP Law360) Singapore ‘image… [read post]
2 Aug 2008, 12:54 am
: (Holman’s Biotech IP Blog), Daiichi’s open offer for 20% in Ranbaxy awaits Sebi nod: (GenericsWeb), Australia/India: Strides shows thumbs up for Indian generic industry acquiring controlling interest in Ascent: (Spicy IP), Europe: Significant date ahead for EU Paediatric Regulation: (SPC Blog), India: Grave diggers, ‘immoral’ patent and the National Biotech Regulatory Authority: (Spicy IP), UK: Monster trade mark infringement case: court reveals its… [read post]
